» Articles » PMID: 3417870

Plasma Clearance of Human Extracellular-superoxide Dismutase C in Rabbits

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1988 Sep 1
PMID 3417870
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular-superoxide dismutase (EC-SOD) is heterogenous in the vasculature with regard to heparin affinity and can be separated into three fractions: A, without affinity; B, with weak affinity; and C, with relatively strong heparin affinity. The plasma clearance of intravenously injected 125I-labeled and unlabeled human EC-SOD C was studied in rabbits. About 90% of injected 125I-EC-SOD C was eliminated from the blood within 5-10 min. Injection of heparin after 10 or 20 min led to an immediate release of all sequestered 125I-EC-SOD C back to the blood plasma. Later injections of heparin led to diminished release, although release could still be demonstrated after 72 h. A half-time of approximately 10 h could be calculated for heparin-releasable 125I-EC-SOD C. Unlabeled EC-SOD C, determined as enzymic activity and with ELISA, was likewise sequestered and released to the same degree as 125I-labeled EC-SOD C by heparin as tested at 20 min and 5 h. The immediacy of the heparin-induced release indicates that the sequestered enzyme had been bound to endothelial cell surfaces. The length of the half-time suggests that the putative cell surface binding has a physiological function and is not primarily a step in enzyme degradation. The distribution of sequestered 125I-labeled EC-SOD C to different organs was determined at times between 10 min and 24 h. Of the organs, the liver contained the most 125I-EC-SOD C, followed by kidney, spleen, heart, and lung. At all investigated times, the content in the analyzed organs was nearly as large as the amount that could be promptly released to plasma by intravenous heparin. This indicates that almost all 125I-EC-SOD C in the organs was present on endothelial cell surfaces and was not bound by other tissue cell surfaces, or was present within the cells.

Citing Articles

Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.

Ander S, Li F, Carpentier K, Morrison T PLoS Pathog. 2022; 18(5):e1010474.

PMID: 35511797 PMC: 9070959. DOI: 10.1371/journal.ppat.1010474.


Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein.

Ferguson M, Saul S, Fragkoudis R, Weisheit S, Cox J, Patabendige A J Virol. 2015; 89(15):7536-49.

PMID: 25972559 PMC: 4505677. DOI: 10.1128/JVI.03645-14.


Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.

Mohammedi K, Bellili-Munoz N, Marklund S, Driss F, Le Nagard H, Patente T Cardiovasc Diabetol. 2015; 14:845.

PMID: 25855220 PMC: 4324771. DOI: 10.1186/s12933-014-0163-2.


Human macrophages limit oxidation products in low density lipoprotein.

Mattsson Hulten L, Ullstrom C, Krettek A, Reyk D, Marklund S, Dahlgren C Lipids Health Dis. 2005; 4:6.

PMID: 15745457 PMC: 555960. DOI: 10.1186/1476-511X-4-6.


Long-term hyperglycaemia decreases vascular fraction of extracellular superoxide dismutase.

Ciechanowski K, Kedzierska K, Herdzik E, Bober J, Domanski L, Borowiak K Diabetologia. 2003; 46(7):1026-7.

PMID: 12830380 DOI: 10.1007/s00125-003-1140-6.


References
1.
Marklund S . Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem. 1976; 251(23):7504-7. View

2.
Marklund S . A simple specific method for the determination of the hemoglobin content of tissue homogenates. Clin Chim Acta. 1979; 92(2):229-34. DOI: 10.1016/0009-8981(79)90117-7. View

3.
Wallinder L, Bengtsson G, Olivecrona T . Rapid removal to the liver of intravenously injected lipoprotein lipase. Biochim Biophys Acta. 1979; 575(1):166-73. DOI: 10.1016/0005-2760(79)90142-5. View

4.
Busch C, Dawes J, Pepper D, Wasteson A . Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res. 1980; 19(1-2):129-37. DOI: 10.1016/0049-3848(80)90412-0. View

5.
Salacinski P, Mclean C, Sykes J, Lowry P . Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem. 1981; 117(1):136-46. DOI: 10.1016/0003-2697(81)90703-x. View